Global Pricing & Access Lead, Rare Haematology

About the role

Alexion, AstraZeneca Rare Disease, is looking for a Director to join its Global Value Access and Pricing (GVAP) team in Barcelona. The role covers the Haematology indication, including near-term new product launches and label expansions, with a particular focus on Paroxysmal Nocturnal Hemoglobinuria (PNH) and HSCT-TMA. It is a strategic position with broad cross-functional exposure, working 3 days in the office and 2 days from home.

Key responsibilities

• Lead the development of a differentiated value proposition for PNH and HSCT-TMA, working with cross-functional teams on evidence-generation plans and real-world evidence, and securing timely country input on evidence plans in priority markets.
• Support the Global Marketing and Market Access Commercial team in advancing PNH lifecycle management through governance milestones, evidence requirements and target product profile needs.
• Develop global market access and pricing strategies, assess pricing and reimbursement risks and opportunities, and create communication tools such as pricing frameworks and negotiation strategies.
• Lead updates to the global PNH reimbursement dossier and market access readiness plans, and represent the GVAP view in the Global Value Sub-Team and Global Launch Team.
• Lead the monthly Haematology, Nephrology and Transplant payer working group and incorporate the patient perspective into market access strategies.
• Support the Haematology pricing strategy, conduct payer and value assessments, partner with the GVAP Expansion Markets team on market-level P&R strategies, and review P&R cases from local markets.
• Provide input to long-term and mid-term plan assumptions, monitor competitor market access and pricing, and communicate with GMMA senior leadership.

Required profile

• More than 6 years of drug development and/or commercialization experience in the pharmaceutical industry.
• Highly specialized rare disease and/or Haematology market access experience.
• Demonstrated leadership, initiative and ability to deliver quality work in uncertain, competitive environments.
• Ability to turn science into a compelling payer value story for leadership and stakeholders.
• Experience developing evidence-based value solutions, for example with EU payers or US commercial customers.
• Relevant graduate degree such as PhD, PharmD, biomedical sciences, business or economics.